Adams, P.C., Reboussin, D.M., & Barton, J.C. (2005). Hemochromatosis and iron-overload screening in a racially diverse population. N Engl J Med. 352: 1769.
Andrews, N.C., & Schmidt, P.J. (2007). Iron homeostasis. Annu Rev Physiolo. 69: 69-85.
Bacon, B.R., Adams, P.C., & Kowdley, K.V. (2011). Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the study of liver diseases. Hepatology. 54: 328.
Beutler, E. (2007). Iron storage disease: Facts, fiction and progress. Blood Cells Mol Dis. 39: 140-147.
Brissot, P., & deBels, F. (2006). Current approaches to the management of hemochromatosis. Hematology Am Soc Hematol Educ Program. 36-41.
Cook, J.D., Flowers, C.H., & Skikne, B.S. (2003). The quantitative assessment of body iron. Blood. 101: 3359.
Edwards, C.Q., Ajoika, R.S., Kushner, J.P. (2000). Hemochromatosis: A genetic definition. Hemochromatosis: Genetics, Pathophysiology, Diagnosis and Treatment. Cambridge Univ Pr. :8-11.
Ganz, T. (2003). Hepcidin, a key regulator of iron metabolism and mediator of anemia and inflammation. Blood. 102(3): 78-80.
Haddy, T.B., Castro, O.L., & Rana, S.R. (1998). Hereditary hemochromatosis in children, adolescents, and young adults. Am J Pediatr Hematol Oncol. 10:23-24.
Hanson, E.H., Imperatore, G., & Burke, W. (2001). HFE gene and hereditary hemochromatosis: a HuGE review. Am J Epidemiol.154: 193.
Higgins, T., Eckfeldt, J.H., Barton, J.C., & Doumas, B.T. (2015). Hemoglobin, iron, and bilirubin. Fundamentals of Clinical Chemistry and Molecular Diagnostics. (7th ed.). Elsevier.
Muncunill, J., Vaquer, P., & Galmes, A. (2002). In hereditary hemochromatosis, red cell apheresis removes excess iron twice as fast as manual whole blood phlebotomy. J Clin Apher. 17:88.
Murtagh, L.J., Whiley, M., & Wilson, S. (2002). Unsaturated iron binding capacity and transferrin saturation are equally reliable in detection of HFE hemochromatosis. Am J Gastroenterol. 97(8): 2093-2099.
Phatak, P.D., Bonkovsky, H.L., & Kowdley, K.V. (2008). Hereditary hemochromatosis: time for targeted screening. Ann Intern Med. 149(4): 270–272.
Qaseem, A., Aronson, M., Fitterman, N., Snow, V., Weiss, K.B., & Owens, D.K. (2005). Screening for hereditary hemochromatosis: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 143: 517-521.
Tavill, A.S. (2001). Diagnosis and management of hemochromatosis. Hepatology. 33: 1321-1328.
Wallace, D.F., Subramaniam, V.N. (2007). Non-HFE haemaochromatosis. World J Gastroenterol. 13(35): 4690-4698.
Whitlock, E.P., Garlitz, B.A., Harris, E.L. (2006). Screening for hereditary hemochromatosis: A systematic review for the U.S. preventive services task force. Ann Intern Med. 145: 209-223.
